Related by context. Frequent words. (Click for all words.) 59 μg kg 59 hypomagnesemia 58 serum uric acid 58 pg mL 58 Cmax 58 leukopenia 58 pg ml 56 T2DM 56 hypercalcemia 56 epoetin 56 ng dL 55 creatinine clearance 55 severe renal impairment 55 glomerular filtration rate 55 chlorambucil 55 irbesartan 55 HbA1C 54 serum sodium 54 achieved statistical significance 54 lymphopenia 54 mcg kg 54 Arch Intern Med 54 PREZISTA r 54 ceftriaxone 54 nmol L 53 mRCC 53 confidence interval #.#-#.# 53 heavily pretreated 53 mg QD 53 epoetin alfa 53 serum phosphorus 53 plus dexamethasone 53 ng ml 53 ACR# response 53 chronic HCV infection 52 annualized relapse 52 systemic embolism 52 peginterferon alfa 2b 52 left ventricular hypertrophy 52 inflammatory lesions 52 mg BID 52 Natalizumab 52 plus methotrexate 52 mg d 52 J Am Coll 52 hemoglobin concentration 52 nM 52 left ventricular systolic 52 laboratory abnormalities 51 mycophenolate mofetil 51 peginterferon alfa 2a 51 mitoxantrone 51 mg kg dose 51 % CI #.#-#.# [006] 51 administered subcutaneously 51 QTc 51 CI -#.# 51 mmol L 51 LEXIVA 51 vitamin D2 51 plasma glucose 51 serum concentrations 51 intramuscularly 50 Neutropenia 50 #mg/kg [002] 50 azacitidine 50 mg dl 50 #mg dose [003] 50 % CI #.#-#.# [007] 50 gout flares 50 ng mL 50 tipranavir 50 dacarbazine 50 Laquinimod 50 LDL C 50 serum PSA 50 FOLFOX 50 febrile neutropenia 50 metastatic renal cell carcinoma 50 thromboembolic events 50 g dL 50 mg calcium 50 cm2 50 DOXIL 50 IU mL 50 plus prednisone 50 Lenalidomide 50 Secondary endpoints include 50 FOLFIRI 50 peginterferon 50 plus ribavirin 49 LDL lowering 49 mg dose 49 placebo p = 49 lopinavir 49 SHPT 49 decitabine 49 HCV genotype 1 49 mcg dose 49 androgen deprivation 49 antihypertensive agents